Autopsy report · NCT03749590
Magnesium Sulfate in the Prevention of Post-ERCP Pancreatitis.
Cause of deathRegulatory or ethics
“The design of the MagPEP trial is no longer in compliance with the current state of science.”
Life of this trial
- Registered 6 years 3 months after it had already started.
- Ran for about 8 years before it stopped.
- 327 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- University Medicine Greifswald
- Sponsor type
- University, hospital or other
- Conditions
- Post-ERCP Pancreatitis
- Interventions
- Magnesium Sulfate; Placebo (NaCl 0,9%)
- Participants
- 327
- Sites
- 1
- Countries
- Germany
Trials that died the same way
- The Impact of Intraoperative Methadone on Postoperative Opioid Use
“The study team will no longer be enrolling patients for this research.” - Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day
“No efficacy could be demonstrated, sponsor decided to prematurely end the study.” - The ENABLE Study: Safety and Efficacy Study of INZ-701 in Patients With ENPP1 Deficiency
“Study was not initiated as it is no longer consistent with the Sponsor's development plans.” - The Effect of Continued Mechanical Ventilation on the Occurrence of Myocardial Ischemia
“After the passing of the principal investigator, the clinical trial could not be continued.” - Dynamic Motor Cortical Responses to Subdural Electrical Stimulation.
“Study team is no longer moving forward with this study.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.